Patent details

Basic Information

Publication number:

EP3424514

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP181906546

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

TNAP+ MESENCHYMAL PRECURSOR CELLS FOR USE IN TREATING CONNECTIVE TISSUE DISEASES

French Title of Invention:

CELLULES PRÉCURSEURS MÉSENCHYMALES TNAP+ POUR L'UTILISATION DANS LE TRAITEMENT DE MALADIES TISSULAIRES CONJONCTIVES

German Title of Invention:

TNAP+ MESENCHYMALE VORLÄUFERZELLEN ZUR VERWENDUNG IN DER BEHANDLUNG VON BINDEGEWEBSERKRANKUNGEN

SPC Number:

Dates

Filing date:

06/08/2008

Grant date:

11/05/2022

EP Publication Date:

09/01/2019

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

11/05/2022

EP B1 Publication Date:

11/05/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

06/08/2022

Expiration date:

06/08/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

04/05/2022

 

 

Name:

Mesoblast, Inc.

Address:

505 Fifth Avenue Level 3, New York, NY 10017, United States (US)

Inventor

Name:

Ghosh, Peter

Address:

Australia (AU)

Priority

1

Priority Number:

2007904212

Priority Date:

06/08/2007

Priority Country:

Australia (AU)

2

Priority Number:

133111 P

Priority Date:

25/06/2008

Priority Country:

United States (US)

Classification

IPC classification:

A61K 35/12; A61K 35/28; A61K 35/32; A61P 19/02; A61P 19/04;

Publication

European Patent Bulletin

Issue number:

202219

Publication date:

11/05/2022

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages